Αρχειοθήκη ιστολογίου

Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174

Πέμπτη 27 Απριλίου 2017

Consensus statement on prevention and management of adverse effects following rejuvenation procedures with Hyaluronic acid based fillers

Abstract

Facial fillers play an important role in the correction of facial changes associated with ageing. They offer quick treatments in the outpatient setting with minimal subsequent downtime that provide predictable, natural-looking, long-lasting results. Hyaluronic acid soft tissue injectables have established their role as the fillers of choice for patients over the last 2 decades. Hyaluronic acid fillers are rarely associated with adverse reactions, and those that do occur tend to be mild and temporary. However, as with all injected or implanted biomaterials, adverse events can occur and patients must be fully informed of potential risks prior to undergoing treatment. A panel of experts from Germany (D), Austria (A) and Switzerland (CH) developed recommendations and this paper provides the 'DACH Consensus Recommendations' from this group specifically on the use of hyaluronic acid fillers. The aim is to help clinicians recognise potential risks and to provide guidance on how best to treat adverse events if they arise. Contra-indications to hyaluronic acid fillers are also detailed and ways to prevent adverse events occurring are discussed. Hyaluronic acid-based products are claimed by some to be very close to fulfilling many of the requirements of an ideal tissue augmentation agent, nevertheless, the potential benefits of treatment must be carefully weighed against the risk of potential adverse events.

This article is protected by copyright. All rights reserved.



http://ift.tt/2oQFrHx

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου